* Poxel announces patient enrollment completed for Imeglimin Phase 2b clinical trial in type
2 diabetes in Japan
The post BRIEF-Poxel completes patient enrollment for Imeglimin Phase 2b clinical trial in type 2 diabetes in Japan appeared first on NASDAQ.